🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the safety and tolerability of XL...
Status
Completed
Location
Investigational Site Number
Start Date
2008-08
Trial ID
NCT00704080
Treatments Being Tested
The purpose of this research study is to test the safety and of adding beva...
Status
Completed
Location
Cincinnati Children's Hospital Medical Center
Start Date
2008-10
Trial ID
NCT00786669
Treatments Being Tested
This is an adaptive design, randomized controlled, Phase 3 clinical trial i...
Status
Terminated
Location
Kaiser Permanente Los Angeles Medical Center
Start Date
2017-10-27
Trial ID
NCT03149575
The goal of this clinical research study is to find the highest tolerable d...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2012-12-18
Trial ID
NCT01596140
Treatments Being Tested
Funding Source - FDA OOPD FDA-approved products for patients with unresect...
Status
Completed
Location
UC San Diego Moores Cancer Center
Start Date
2018-09-12
Trial ID
NCT03556384
Treatments Being Tested
The main objective of this study is to investigate whether administration o...
Status
Terminated
Location
Multiple Locations
Start Date
2008-03-04
Trial ID
NCT00632203
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability, and the...
Status
Unknown
Location
New York University
Start Date
2010-05
Trial ID
NCT01107522
Treatments Being Tested
The proposed phase I/II study of disulfiram (DSF) for patients with presume...
Status
Completed
Location
Washington University School of Medicine
Start Date
2016-06-15
Trial ID
NCT02715609
Treatments Being Tested
This single-arm phase II study will assess the impact of tetanus pre-condit...
Status
Terminated
Location
Duke University Medical Center
Start Date
2019-09-30
Trial ID
NCT03927222
The purpose of this phase 2 study is to assess the efficacy and patient sat...
Status
Completed
Location
The Preston Robert Tisch Brain Tumor Center at Duke
Start Date
2017-10-09
Trial ID
NCT02991456
Treatments Being Tested